These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction. Bercu BB; Root AW; Shulman DI J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032 [TBL] [Abstract][Full Text] [Related]
49. Effects of alpha- and beta-adrenergic agonists and antagonists on growth hormone secretion in man. Mazza E; Ghigo E; Bellone J; Arvat E; Revelli E; Cella SG; Brambilla F; Müller EE; Camanni F Endocrinol Exp; 1990 Mar; 24(1-2):211-9. PubMed ID: 1972919 [TBL] [Abstract][Full Text] [Related]
50. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep. Magnan E; Cataldi M; Guillaume V; Mazzocchi L; Dutour A; Razafindraibe H; Sauze N; Renard M; Oliver C Endocrinology; 1994 Feb; 134(2):562-7. PubMed ID: 7905408 [TBL] [Abstract][Full Text] [Related]
51. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. Uhde TW; Tancer ME; Rubinow DR; Roscow DB; Boulenger JP; Vittone B; Gurguis G; Geraci M; Black B; Post RM Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485 [TBL] [Abstract][Full Text] [Related]